Company: SHPH
Filing Date: 2025-03-13
Form Type: 424B3
Source: 0001493152-25-010109
Chunk: 51

Company: Shuttle Pharmaceuticals Holdings, Inc.
Filing Date: 2025-03-13
Form: 424B3
Chunk 51
---
 above is as of December 31, 2024 and excludes:

| ● | Up                                                                                                                            
 to 861,334 shares of our common stock issuable from time to time upon the conversion of outstanding Convertible Bridge Notes; |
| ● | 3,464,281                                                                                                                     
 shares of our common stock issuable upon the                                                                                  
 exercise of outstanding warrants, with a weighted-average exercise price of $1.89 per share; and                              |
| ● | 679,424                                                                                                                       
 other shares of our common stock reserved for                                                                                 
 future issuance from time to time under our 2018 Equity Incentive Plan.                                                       |

| 34 |

<div align='center'>DIVIDEND POLICY</div>

We have not paid any dividends on our common stock since inception and we currently expect that, in the foreseeable future, all earnings, if any, will be retained for the development of our business and no dividends will be declared or paid. Any future dividends will be subject to the discretion of our board of directors and will depend upon, among other things, our earnings, if any, operating results, financial condition and capital requirements, general business conditions and other pertinent facts.

<div align='center'>DESCRIPTION OF CAPITAL STOCK</div>

Capital Stock

Our authorized capital stock consists of 100,000,000 shares of common stock, par value $0.00001 per share, and 20,000,000 shares of preferred stock, par value $0.00001 per share.

Common Stock

As of the date of this prospectus, we had 4,916,772 shares of common stock issued and outstanding. Each holder of common stock is entitled to one vote for each share owned on all matters voted upon by stockholders, and a majority vote is required for all actions to be taken by stockholders. In the event we liquidate, dissolve or wind-up our operations, the holders of the common stock are entitled to share equally and ratably in our assets, if any, remaining after the payment of all our debts and liabilities and the liquidation preference of any shares of preferred stock that may then be outstanding. The common stock has no preemptive rights, no cumulative voting rights, and no redemption, sinking fund, or conversion provisions.

Holders of common stock are entitled to receive dividends, if and when declared by the board of directors, out of funds legally available for such purpose, subject to the dividend and liquidation rights of any preferred stock that may then be outstanding.

Preferred Stock